rs120074123
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000543.5(SMPD1):c.1154A>G(p.Asn385Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461684Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727116
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Niemann-Pick disease, type B Pathogenic:1
- -
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:1
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Asn385 amino acid residue in SMPD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 1618760). ClinVar contains an entry for this variant (Variation ID: 2988). This variant is also known as N383S. This missense change has been observed in individual(s) with Niemann-Pick disease (PMID: 1618760, 33675270). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 385 of the SMPD1 protein (p.Asn385Ser). -
Sphingomyelin/cholesterol lipidosis Pathogenic:1
The p.Asn385Ser variant in SMPD1 (also known as p.Asn383Ser due to a difference in cDNA numbering) has been reported in at least 1 individual with Niemann-Pick disease (PMID: 26049896, 16010684, 1618760) and was absent from large population studies. This variant has also been reported in ClinVar (VariationID: 2988) as pathogenic by OMIM. In vitro functional studies provide some evidence that the p.Asn385Ser variant may impact protein function (PMID: 26499107, 1618760). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The p.Asn385Ser variant is located in a region of SMPD1 that is essential to protein folding and stability, suggesting that this variant is in a functional domain and supports pathogenicity (PMID: 26499107, 15557261). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PS3, PM2, PM1, PP3 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at